SEC Form 5 · accession 0001570523-18-000013
Immune Therapeutics, Inc. · IMUN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Dec 31, 2017
Accepted (ET)
Mar 30, 2018 · 2:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001559356
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Mar 16, 2016 | P | 1,000 | $0.18 | A | 20,800,359 | D | |
| Common stock | Mar 16, 2016 | P | 1,000 | $0.18 | A | 20,800,359 | D | |
| Common stock | Mar 16, 2016 | P | 5,000 | $0.1799 | A | 20,800,359 | D | |
| Common stock | Mar 16, 2016 | P | 1,250 | $0.1764 | A | 20,800,359 | D | |
| Common stock | Mar 16, 2016 | P | 3,750 | $0.18 | A | 20,800,359 | D | |
| Common stock | Mar 16, 2016 | P | 500 | $0.165 | A | 20,800,359 | D | |
| Common stock | Mar 16, 2016 | P | 6,900 | $0.1692 | A | 20,800,359 | D | |
| Common stock | Mar 16, 2016 | P | 1,200 | $0.1816 | A | 20,800,359 | D | |
| Common stock | Mar 16, 2016 | P | 6,900 | $0.17 | A | 20,800,359 | D | |
| Common stock | Mar 16, 2016 | P | 2,000 | $0.19 | A | 20,800,359 | D | |
| Common stock | Mar 16, 2016 | P | 1,000 | $0.19 | A | 20,800,359 | D | |
| Common stock | Mar 17, 2016 | P | 11,200 | $0.19 | A | 20,800,359 | D | |
| Common stock | Mar 17, 2016 | P | 500 | $0.1879 | A | 20,800,359 | D | |
| Common stock | Mar 17, 2016 | P | 5,000 | $0.17 | A | 20,800,359 | D | |
| Common stock | Mar 18, 2016 | P | 1,100 | $0.1699 | A | 20,800,359 | D | |
| Common stock | Mar 18, 2016 | P | 10,000 | $0.1685 | A | 20,800,359 | D | |
| Common stock | Mar 21, 2016 | P | 10,000 | $0.1545 | A | 20,800,359 | D | |
| Common stock | Mar 21, 2016 | P | 1,000 | $0.1545 | A | 20,800,359 | D | |
| Common stock | Mar 22, 2016 | P | 1,603 | $0.154 | A | 20,800,359 | D | |
| Common stock | Mar 22, 2016 | P | 8,397 | $0.1539 | A | 20,800,359 | D | |
| Common stock | Mar 24, 2016 | P | 40,000 | $0.146 | A | 20,800,359 | D | |
| Common stock | Mar 24, 2016 | P | 20,000 | $0.146 | A | 20,800,359 | D | |
| Common stock | Mar 24, 2016 | P | 20,000 | $0.146 | A | 20,800,359 | D | |
| Common stock | Mar 24, 2016 | P | 20,000 | $0.15 | A | 20,800,359 | D | |
| Common stock | Mar 24, 2016 | P | 1,250 | $0.1568 | A | 20,800,359 | D | |
| Common stock | Mar 24, 2016 | P | 781 | $0.1588 | A | 20,800,359 | D | |
| Common stock | Mar 24, 2016 | P | 4,219 | $0.1589 | A | 20,800,359 | D | |
| Common stock | Mar 24, 2016 | P | 8,750 | $0.1589 | A | 20,800,359 | D | |
| Common stock | Mar 24, 2016 | P | 5,000 | $0.1563 | A | 20,800,359 | D | |
| Common stock | Mar 24, 2016 | P | 2,000 | $0.1569 | A | 20,800,359 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
This is part 9 of 16 submissions.